Bookimed does not add extra charges for CAR T-cell therapy prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your CAR T-cell therapy upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in CAR T-cell therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your CAR T-cell therapy journey.
| The USA | Turkey | Mexico | |
| CAR T-cell therapy | from $165000 | from $55000 | from $63250 |
Policlinico San Donato is a leading Italian clinic for cardiology and cardiac surgery.
Doctors perform over 9,400 open and minimally invasive operations on the heart and blood vessels annually. It is the largest number in the country.
Сardiology, heart surgery, arrhythmology, and rehabilitation are the top specialities in San Donato Hospital.
Ospedale San Raffaele (San Raffaele Research Hospital) in Milan is one of the largest research hospitals in Europe. It applies ad hoc methods for rare immune system and genetic diseases treatment.
Among its achievements — the world's first stem cell therapy for patients with severe combined immune deficiency disorder (ADA-SCID).
Oncology, oncohematology, neurosurgery, neurology, cardiovascular surgery, urology, and gynecology are the strongest specialities here.
Surgeons of the hospital perform over 52,000 operations annually.
Professor Fabio Ciceri is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Gene Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.